Cargando…

Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes

Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of major adverse cardiovascular (CV) events and hospitalization for heart failure (HF) in patients with type 2 diabetes (T2D). Using CV MRI (CMR) and (31)P-MRS in a longitudinal cohort study, we aimed to investigate the effects of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thirunavukarasu, Sharmaine, Jex, Nicholas, Chowdhary, Amrit, Hassan, Imtiaz Ul, Straw, Sam, Craven, Thomas P., Gorecka, Miroslawa, Broadbent, David, Swoboda, Peter, Witte, Klaus K., Cubbon, Richard M., Xue, Hui, Kellman, Peter, Greenwood, John P., Plein, Sven, Levelt, Eylem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660983/ https://www.ncbi.nlm.nih.gov/pubmed/34610982 http://dx.doi.org/10.2337/db21-0270

Ejemplares similares

Cardiac Adaptations to Acute Hemodynamic Stress in Function, Perfusion, and Energetics in Type 2 Diabetes With Overweight and Obesity
por: Chowdhary, Amrit, et al.
Publicado: (2022)

Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes
por: Chowdhary, Amrit, et al.
Publicado: (2022)

Rationale and design of the randomised controlled cross-over trial: Cardiovascular effects of empaglifozin in diabetes mellitus
por: Thirunavukarasu, Sharmaine, et al.
Publicado: (2021)

Global microvascular ischaemia following Takotsubo cardiomyopathy with left ventricular function recovery
por: Chowdhary, Amrit, et al.
Publicado: (2021)

A case report of refractory angina in a patient with diabetes and apical hypertrophic cardiomyopathy
por: Jex, Nicholas, et al.
Publicado: (2022)

Multiple Etiologies to Myocardial Injury in COVID-19
por: Gorecka, Miroslawa, et al.
Publicado: (2021)

Coexistent Diabetes Is Associated With the Presence of Adverse Phenotypic Features in Patients With Hypertrophic Cardiomyopathy
por: Jex, Nicholas, et al.
Publicado: (2022)

A 30-Year-Old Man With Primary Cardiac Angiosarcoma
por: Jex, Nicholas, et al.
Publicado: (2021)

Progressive myocardial dysfunction following COVID-19
por: Gorecka, Miroslawa Maria, et al.
Publicado: (2021)

Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: a prospective case–control study
por: Gorecka, Miroslawa, et al.
Publicado: (2022)

Prospective Longitudinal Characterization of the Relationship between Diabetes and Cardiac Structural and Functional Changes
por: Chowdhary, Amrit, et al.
Publicado: (2022)

Association Between Type 2 Diabetes and Changes in Myocardial Structure, Contractile Function, Energetics, and Blood Flow Before and After Aortic Valve Replacement in Patients With Severe Aortic Stenosis
por: Jex, Nicholas, et al.
Publicado: (2023)

Cardiovascular magnetic resonance phenotyping of heart failure with mildly reduced ejection fraction
por: Brown, Louise A E, et al.
Publicado: (2022)

Maternal Cardiac Changes in Women With Obesity and Gestational Diabetes Mellitus
por: Thirunavukarasu, Sharmaine, et al.
Publicado: (2022)

Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes
por: Das, Arka, et al.
Publicado: (2021)

Cardiac reverse remodeling in primary mitral regurgitation: mitral valve replacement vs. mitral valve repair
por: Craven, Thomas P., et al.
Publicado: (2023)

Sex- and age-specific normal values for automated quantitative pixel-wise myocardial perfusion cardiovascular magnetic resonance
por: Brown, Louise A E, et al.
Publicado: (2022)

Exercise cardiovascular magnetic resonance: feasibility and development of biventricular function and great vessel flow assessment, during continuous exercise accelerated by Compressed SENSE: preliminary results in healthy volunteers
por: Craven, Thomas P., et al.
Publicado: (2020)

Myocardial inflammation and energetics by cardiac MRI: a review of emerging techniques
por: Tsampasian, Vasiliki, et al.
Publicado: (2021)

A comparison of standard and high dose adenosine protocols in routine vasodilator stress cardiovascular magnetic resonance: dosage affects hyperaemic myocardial blood flow in patients with severe left ventricular systolic impairment
por: Brown, Louise A. E., et al.
Publicado: (2021)

Identification of non-ischaemic fibrosis in male veteran endurance athletes, mechanisms and association with premature ventricular beats
por: Farooq, Maryum, et al.
Publicado: (2023)

Diabetes mellitus and the causes of hospitalisation in people with heart failure
por: Malik, Anam, et al.
Publicado: (2022)

Detrimental Immediate- and Medium-Term Clinical Effects of Right Ventricular Pacing in Patients With Myocardial Fibrosis
por: Saunderson, Christopher E.D., et al.
Publicado: (2021)

Quantifying Myocardial Blood Flow and Resistance Using 4D-Flow Cardiac Magnetic Resonance Imaging
por: Gosling, Rebecca C., et al.
Publicado: (2023)

Reduction of heart failure guideline‐directed medication during hospitalization: prevalence, risk factors, and outcomes
por: Palin, Victoria, et al.
Publicado: (2022)

Regression of Left Ventricular Mass in Athletes Undergoing Complete Detraining Is Mediated by Decrease in Intracellular but Not Extracellular Compartments
por: Swoboda, Peter P., et al.
Publicado: (2019)

Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2022)

Cardiac magnetic resonance left ventricular filling pressure is linked to symptoms, signs and prognosis in heart failure
por: Grafton‐Clarke, Ciaran, et al.
Publicado: (2023)

Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: a comprehensive review
por: Gorecka, Miroslawa, et al.
Publicado: (2022)

Early prediction of left ventricular function improvement in patients with new-onset heart failure and presumed non-ischaemic aetiology
por: Goh, Ze Ming, et al.
Publicado: (2023)

Reproducibility of strain and twist measurements calculated using CSPAMM tagging
por: Swoboda, Peter, et al.
Publicado: (2011)

Clinical Translation of Three-Dimensional Scar, Diffusion Tensor Imaging, Four-Dimensional Flow, and Quantitative Perfusion in Cardiac MRI: A Comprehensive Review
por: Paddock, Sophie, et al.
Publicado: (2021)

Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study
por: Gaborit, B., et al.
Publicado: (2021)

Feasibility and validation of trans-valvular flow derived by four-dimensional flow cardiovascular magnetic resonance imaging in pacemaker recipients
por: Saunderson, Christopher E.D., et al.
Publicado: (2020)

Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy
por: Caspi, Talia, et al.
Publicado: (2020)

Myocardial steatosis, impaired energetics and reduced circumferential strain are early manifestations of diabetic cardiomyopathy and precede structural changes
por: Levelt, Eylem, et al.
Publicado: (2014)

Attenuation of Adverse Postinfarction Left Ventricular Remodeling with Empagliflozin Enhances Mitochondria-Linked Cellular Energetics and Mitochondrial Biogenesis
por: Song, Yang, et al.
Publicado: (2021)

Male sex adversely affects the phenotypic expression of diabetic heart disease
por: Athithan, Lavanya, et al.
Publicado: (2020)

Effect of exercise on myocardial energy metabolism and relationship between coronary microvascular dysfunction and abnormal myocardial energetics in diabetic cardiomyopathy
por: Levelt, Eylem, et al.
Publicado: (2015)

Single bolus versus split dose gadolinium administration in extra-cellular volume calculation at 3 Tesla
por: McDiarmid, Adam K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6osp3b25loqr3urka7svv6bd61